Sign In
Buy LKYSF
$0.390
+0 (+0%)
At Close: Aug 17, 2022
Numinus Wellness plans expansion of psychedelics research laboratory
09:06am, Tuesday, 09'th Mar 2021
Numinus Wellness Inc (CVE:NUMI) (FRA:LR23) said it is planning to significantly expand its psychedelics research laboratory by late 2021. The psychedelic-focused healthcare and research company said
Numinus Wellness receives license amendments to strengthen its ability to lead psychedelics research and support the global sector
11:27am, Thursday, 04'th Mar 2021
Numinus Wellness Inc (CVE:NUMI), a global leader in supporting and expanding the safe, accessible, and evidence-based use of psychedelic-assisted psychotherapies (PAP), has received new amendments und
Numinus Wellness says making good progress in its compassionate access study of psilocybin-assisted motivational enhancement therapy
10:32am, Tuesday, 02'nd Mar 2021
Numinus Wellness Inc (CVE:NUMI) told investors that it is making “significant progress” in its compassionate access trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME)
As “Shrooms” Fix the World's Largest Healthcare Crisis, This Tiny Stock Will Soar
09:30am, Monday, 01'st Mar 2021
Numinus Wellness (LKYSF) is an integrated mental health company focused on developing and delivering psychedelic-assisted psychotherapies. The post As “Shrooms” Fix the World's Largest Healthcare
Numinus Wellness looking to position itself at the forefront of psychedelics for healing and wellness
10:03am, Friday, 19'th Feb 2021
Trifecta of psychedelics healing and wellness solutions Numinus Bioscience is a Health Canada-licensed lab Numinus R&D is developing psychedelic-assisted therapeutic protocols Numinus Health supports
Numinus Wellness's trial for MDMA-assisted therapy is in pre-implementation stage
08:59am, Thursday, 18'th Feb 2021
Numinus Wellness Inc (CVE:NUMI) (OTCMKTS:LKYSF) (FRA:LR23) updated Thursday on the progress of its first-of-its-kind trial in Canada for MDMA-assisted therapy for treating patients with posttraumatic
Numinus Wellness closes acquisition of Mindspace Psychology Services, a leader and pioneer in psychedelic programming
10:19am, Monday, 08'th Feb 2021
Numinus Wellness Inc. (CVE:NUMI) said it has closed its acquisition of Mindspace Psychology Services Inc. (DBA Mindspace Wellbeing), a leader and pioneer in psychedelic programming, as previously an
10 Stocks Under $10 to Buy Before They Soar
09:05am, Wednesday, 27'th Jan 2021
One of the counterintuitive dynamics of the pandemic-disrupted year in 2020 was the rise of Wall Street. But that doesn't mean you've missed the boat, as these stocks under $10 demonstrate.
Numinus: A Bet On The Changing Landscape Of Therapeutic Drugs
01:07pm, Sunday, 27'th Dec 2020
The Canadian government continues to make moves in favour of psychedelics. Diagnosis rates of depression and anxiety are higher than ever, pathing a way for psychedelics to become a legit alternative
Psychedelic Stocks News: Why MMEDF and NUMI Are Soaring Monday
12:05pm, Monday, 14'th Dec 2020
Psychedelic stocks are taking off on Monday with MindMed (MMEDF) and Numinus Wellness (LKYSF) seeing major spikes in trading. The post Psychedelic Stocks News: Why MMEDF and NUMI Are Soaring Monday ap
